Screening new drugs with stem cells

| June 7, 2012
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Mass producing stem cells to screen drugs and study the progress of disease is not the sexier side of the field.  But it’s getting more attention now–and it’s about time.

View the original article here: Screening New Drugs With Stem Cells – Forbes

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend